Allurion Technologies, Inc. (ALUR) Dividend History

Allurion Technologies, Inc. is a healthcare company specializing in developing non-invasive weight management solutions. Known for its flagship product, the Allurion Elipse Balloon, it offers a swallowable, fully dissolvable gastric balloon designed to help individuals achieve weight loss through portion control and lifestyle changes. The company's technology aims to provide a less invasive alternative to traditional bariatric procedures, focusing on improving health outcomes and quality of life for patients struggling with obesity.

11 Huron Dr Ste 200, Natick, MA, 01760
Phone: 508-647-4000
Website:

Dividend History

Allurion Technologies, Inc. currently does not pay dividends

Company News

  • The article highlights four promising penny stocks with high-risk, high-reward potential: Allurion Technologies, Lucid Diagnostics, KULR Technology Group, and Gevo. These companies operate in diverse industries, including weight loss management, medical diagnostics, sustainable energy, and renewable fuels.

    Benzinga
    Featured Companies: GEVO KULR LUCD
  • Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.

    Zacks Investment Research
    Featured Companies: BSX DVA ECL
  • The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

    Zacks Investment Research
  • U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88. The S&P 500 also fell, dropping, 0.28% to 5,197.03. Check This Out: Insiders Buying Walgreens And 2 Other Stocks   Leading and Lagging Sectors   Communication services shares jumped by 1.1% on Thursday. In trading on Thursday, health care shares rose by just 0.1%.   Top Headline   Shares of RPM International Inc. (NYSE: RPM) fell more than 5% on Thursday after the company reported third-quarter FY24 results. Sales rose 0.4% Y/Y to $1.523 billion, slightly beating the consensus of $1.518 billion. Adjusted EPS of 52 cents exceeded the consensus of 46 cents.   Equities Trading UP   TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares shot up 59% to $2.0597. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies. Shares of Allurion Technologies Inc. (NASDAQ: ALUR) got a boost, surging 101% to $3.46 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock ...

    Benzinga
    Featured Companies: CADL KWE RPM
  • Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies. Allurion Technologies Inc. (NASDAQ: ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target. Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development. HWH International Inc. (NASDAQ: HWH) gained 38.8% to $2.1765. Candel Therapeutics, Inc. (NASDAQ: CADL) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer. MacroGenics, Inc. (NASDAQ: MGNX) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting. E-Home Household Service Holdings Limited (NASDAQ: EJH) gained 27% to $2.22. Reliance Global Group, Inc. (NASDAQ: RELI) gained 24.6% to $0.46 after the company reported FY23 earnings. Simulations Plus, Inc. (NASDAQ: SLP) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter. Vast Renewables Limited (NASDAQ: VSTE) gained 22.3% to $8.81. Sportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss. Gorilla Technology Group Inc. (NASDAQ: GRRR) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results. Levi Strauss & Co. (NYSE: LEVI) shares rose 18.3% to $22.10 after the company reported upbeat earnings ...

    Benzinga
Dividend data last updated 06/07/2025 15:31:03 UTC